Enfortumab Vedotin & Bladder Cancer: Thomas Powles, MD ESMO 2023 Bladder 2 Mins Read25 By: Thomas Powles, MD Date: October 25, 2023 An exclusive interview occurred with Dr. Thomas Powles, MD, the lead investigator…
Advanced Head and Neck Cancer: Enfortumab Vedotin the EV-202 Cohort Head and Neck 3 Mins Read2 Dr. Jessica Geiger from Cleveland Clinic presented an abstract at ASCO 2023 highlighting the potential of Enfortumab vedotin as a…
Abemaciclib: 2023 Kidney Cancer Breakthroughs Rana McKay, MD Slides Kidney 20 Mins Read3 Belzutifan and other Novel Therapies in Genitourinary Oncology 2023 By Rana McKay, MD – University of California San Diego We’re…
